Plasmacytoid Dendritic Cells: From Heart to Vessels
International Journal of Vascular Medicine · 2010
DOI: 10.1155/2010/430318 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Vascular Medicine, 2010. Verfasst von Rosalinda Sorrentino und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Science Department, University of Salerno, 84084 Fisciano, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Cardiovascular diseases, formerly only attributed to the alterations of the stromal component, are now recognized as immune-based pathologies. Plasmacytoid Dendritic Cells (pDCs) are important immune orchestrators in heart and vessels. They highly produce IFN type I that promote the polarization of T cells towards a Th1 phenotype; however, pDCs can also participate to suppressive networks via the recruitment of T regulatory cells that downmodulate proinflammatory responses. pDCs populate the vessel wall layers during pathological conditions, such as atherosclerosis. It is thus clear that a better identification of pDCs activity in cardiovascular diseases can not only elucidate pathological mechanisms but also lead to new therapeutic approaches.
Autor:innen und Institutionen
- Pharmaceutical Science Department, University of Salerno, 84084 Fisciano, Italy.
Zitieren
APA
Sorrentino, R., Morello, S., & Pinto, A. (2010). Plasmacytoid Dendritic Cells: From Heart to Vessels. International Journal of Vascular Medicine. https://doi.org/10.1155/2010/430318
Vancouver
Sorrentino R, Morello S, Pinto A. Plasmacytoid Dendritic Cells: From Heart to Vessels. International Journal of Vascular Medicine. 2010. doi:10.1155/2010/430318
BibTeX
@article{Sorrentino2010,
author = {Sorrentino, Rosalinda and Morello, Silvana and Pinto, Aldo},
title = {Plasmacytoid Dendritic Cells: From Heart to Vessels},
journal = {International Journal of Vascular Medicine},
year = {2010},
doi = {10.1155/2010/430318}
}
EUVIMED